Studien | Der Arzneimittelbrief

APRICOT

Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis

APRICOT 2

Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis 2

APRIL

A Double-Blind, Placebo-Controlled, Randomized, Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke

APRIL-OCELOT

Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids

APRIS

Aortic Plaque and Risk of Ischemic Stroke study

APROCCHSS

Activated Protein C and Corticosteroids for Human Septic Shock

APrODiTe-2

Assessment of Blood Pressure Control and Target Organ Damage in Patients with Chronic Kidney Disease and Hypertension-2

APrON

Alberta Pregnancy Outcomes and Nutrition (1)

APrON

Alberta Pregnancy Outcomes and Nutrition (2)

APROS

Assessment of Prognostic Risk Observational Survey

APROS-diadys

Assessment of PRevalence Observational Study of DIAstolic DYSfunction

APSI

Acebutolol et Prevention Secondaire de l'Infarctus

APSIS

Angina Prognosis Study with Isoptin and Seloken

APT

Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer

APT-Sepsis

Active Prevention and Treatment of Maternal Sepsis

APTH

Ambulatory blood Pressure monitoring and Treatment of Hypertension

Antagonize P2Y12 Treatment Inhibitors by Transfusion of Platelets in an Urgent or Delayed Timing After Acute Coronary Syndrome or Percutaneous Coronary Intervention Presentation-Acute Coronary Syndrom

APTITUDE-CABG

APTITUDE-Coronary Artery Bypass Graft

AQUA

American Urological Association Quality Registry

AQUA

Asking QUestions about Alcohol in pregnancy

AQUA

Audit and QUality control in Angioplasty

AQUA

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME

AQUAMARINE EPA/DHA

Attempts at Plaque Vulnerability Quantification with Magnetic Resonance Imaging Using Non-contrast T1-weighted Technic

AQUAMAT

African Quinine Artesunate Malaria Trial

AQUATIC

Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

AQUEDUCT

Achieving Quality and Effectiveness in Dementia Using Crisis Teams

Aqueous-PREP

Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures

AQUILA

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

AQUILA

A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

AQUILA

Real world data on secukinumab's effectiveness in psoriatic arthritis patients

AQuIRE

ACCP Quality Improvement Registry Education and Evaluation

AQVA

Angio-based Quantitative Flow Ratio Virtual PCI Versus Conventional Angio-guided PCI in the Achievement of an Optimal Post-PCI QFR

AQVA-II

Physiology Optimized Versus Angio-guided PCI

ARAAT

Androgen-Receptor pAthwAy inhibitors Triplet therapy for metastatic hormone-sensitive prostate cancer

ARADES

Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer

ARAFOR

Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer

ARAIS

Argatroban Plus R-tPA for Acute Ischemic Stroke

ARAMIS

A Randomized Multicenter Study for Isolated Skin Vasculitis

ARAMIS

Addressing Real-world Anticoagulant Management Issues in Stroke

ARAMIS

Androgen Receptor Antagonizing agent for MetastasIs-free Survival

ARAMIS

Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension

ARAMIS

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke

ARAMIS

Arthritis, Rheumatism, and Aging Medical Information System

ARAMON

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

ARANOTE

Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

ARAPACIS

Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study

ARASAFE

A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

ARASEC

A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study

ARASENS

Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer

ARASTEP

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

ARBITER

Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol

ARBITER 2

Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 2

ARBITER 3

Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 3

ARBITER 6-HALTS

Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 6-HDL And LDL treatment Strategies in atherosclerosis